Dexamethasone intravitreal implant for macular edema: a pilot study in a public health center

Dexamethasone intravitreal implant for macular edema: a pilot study in a public health center

Introduction: Macula edema consists in one of the most common causes of visual impairment. Objective: To evaluate the safety and efficacy of continuous release of 0.7 mg dexamethasone (using implantable device) for treatment of macular edema. Methods: Cross-sectional observational study of 16 patien...

Full description

Bibliographic Details
Main Authors:	Maria Júlia Izzo Crespo, Cristina Nery Carbajo, Glaucia Luciano da Veiga, Fernando Luiz Affonso Fonseca, Vagner Loduca Lima, Júlio Zaki Abucham Neto
Format:	Article
Language:	English
Published:	Faculdade de Medicina do ABC 2020-12-01
Series:	ABCS Health Sciences
Subjects:	intravitreal dexamethasone implant macular edema anti-vascular endothelial growth factor diabetes
Online Access:	https://www.portalnepas.org.br/abcshs/article/view/1851

Similar Items

Dexamethasone intravitreal implant in cystoid macular edema secondary to paclitaxel therapy
by: Barbara Burgos-Blasco, et al.
Published: (2020-06-01)

Bilateral Intravitreal Dexamethasone Implant for Retinitis Pigmentosa-Related Macular Edema
by: Ali Osman Saatci, et al.
Published: (2013-03-01)

Intravitreal Dexamethasone Implant for the Treatment of Patient with Resistant to Anti-VEGF Diabetic Macular Edema
by: M. M. Bikbov, et al.
Published: (2020-08-01)

Title: efficacy of intravitreal dexamethasone implant on hard exudate in diabetic macular edema
by: Chang Ki Yoon, et al.
Published: (2021-01-01)

Widening use of dexamethasone implant for the treatment of macular edema
by: Bonfiglio V, et al.
Published: (2017-08-01)

Results of dexamethasone implant in macular edema of variable etiologies [Farkli etyolojilere bagli makula odeminde intravitreal deksametazon implantasyonu sonuclari]
by: Taner Kar, et al.
Published: (2016-09-01)

Research progress of intravitreal Dexamethasone implant in the treatment of non-infectious uveitic macular edema
by: Xiao-Guang Zhang, et al.
Published: (2020-02-01)

Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema
by: Santosh Kumar Mahapatra, et al.
Published: (2020-01-01)

Effect of dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes of Taiwanese patients with treatment-naïve diabetic macular edema
by: Jia-Kang Wang, et al.
Published: (2020-11-01)

Real-world experience with pro re nata dosing of intravitreal dexamethasone implant for eyes with refractory diabetic macular edema
by: Rishi, Pukhraj, et al.
Published: (2020-04-01)

Evaluation of efficacy dexamethasone intravitreal implant compared to treatment with anti-VEGF in the treatment of diabetic macular edema
by: Elena Pacella, et al.
Published: (2014-12-01)

Dexamethasone implant in the management of diabetic macular edema from clinician’s perspective
by: Urbančič M, et al.
Published: (2019-05-01)

Repeated Treatment for Macular Edema in Vein Occlusion by Intravitreal Implant of Dexamethasone
by: Frederic Matonti, et al.
Published: (2012-10-01)

Short-term results of intravitreal dexamethasone implant (OZURDEX®) in treatment of recalcitrant diabetic macular edema: A case series
by: Pukhraj Rishi, et al.
Published: (2012-01-01)

The Efficacy of Single-Dose Intravitreal Dexamethasone Implant for Diabetic Macular Edema Refractory to Anti-VEGF Therapy: Real-Life Results
by: Mert Simsek, et al.
Published: (2020-02-01)

Intravitreal Dexamethasone Implants for Refractory Macular Edema in Eyes with Noninfectious Uveitis
by: Eugene Yu-Chuan Kang, et al.
Published: (2021-08-01)

Comparative characteristics of the outcomes of the use of multidirectional intravitreal pharmacotherapy in the treatment of diabetic macular edema
by: M. M. Bikbov, et al.
Published: (2021-04-01)

Short-Term Outcomes of Refractory Diabetic Macular Edema Switch From Ranibizumab to Dexamethasone Implant and the Influential Factors: A Retrospective Real World Experience
by: Ning-Yi Hsia, et al.
Published: (2021-04-01)

The Efficacy and Safety of Intravitreal Dexamethasone Implant for the Treatment of Macular Edema Related to Retinal Vein Occlusion: Real-life Data and Prognostic Factors in a Turkish Population
by: Ayşe Yağmur Kanra, et al.
Published: (2017-12-01)

Intravitreal dexamethasone implants for diabetic macular edema
by: Alicia Pareja-Ríos, et al.
Published: (2018-01-01)

Intravitreal Injection of Dexamethasone Implant and Ranibizumab in Cystoid Macular Edema in the Course of Irvine-Gass Syndrome
by: Vito Fenicia, et al.
Published: (2014-08-01)

Budget impact analysis of dexamethasone intravitreal implant for the treatment of diabetic macular oedema
by: Fernando de Andrés-Nogales, et al.
Published: (2018-11-01)

Dexamethasone intravitreal implant (Ozurdex) in diabetic macular edema: real-world data versus clinical trials outcomes
by: Pedro Neves, et al.
Published: (2021-10-01)

Macular Electrophysiology After Intravitreal Dexamethasone Implant in Patients with Branch Retinal Vein Occlusion
by: Muhammed Nurullah Bulut, et al.
Published: (2020-03-01)

Intravitreal Dexamethasone Implant (Ozurdex) for Refractory Macular Edema Secondary to Retinitis Pigmentosa
by: Nurgül Örnek, et al.
Published: (2016-08-01)

Diabetic macular edema: a literature review
by: Wellington Fernando Risso, et al.
Published: (2020-12-01)

INTRAVITREAL IMPLANT OF DEXAMETHASONE IN THE TREATMENT OF RETINAL VEIN OCCLUSION: EFFICACY AND SAFETY
by: A. E. Yavorskiy, et al.
Published: (2015-10-01)

OCTA as evaluation methods for the efficacy and safety of Dexamethasone intravitreal implants for retinal vein occlusion-related macular edema
by: Chan Li, et al.
Published: (2020-08-01)

Comparison of the Safety and Efficacy of Intravitreal Ranibizumab with or without Laser Photocoagulation Versus Dexamethasone Intravitreal Implant with or without Laser Photocoagulation for Macular Edema Secondary to Branch Retinal Vein Occlusion
by: Kumar Prashant, et al.
Published: (2019-06-01)

Intravitreal bevacizumab plus macular laser photocoagulation for treatment of diabetic macular edema
by: Ahmed H Mohamed
Published: (2016-01-01)

Anatomical and functional changes after dexamethasone implant and ranibizumab in diabetic macular edema: a retrospective cohort study
by: Leonardo Mastropasqua, et al.
Published: (2019-10-01)

Long-term results of combination therapy using anti-VEGF agents and dexamethasone intravitreal implant for retinal vein occlusion: an investigational case series
by: Singer MA, et al.
Published: (2016-12-01)

The effects of intravitreal adalimumab injection on pseudophakic macular edema
by: Mohsen Farvardin, et al.
Published: (2020-07-01)

Efficacy of Intravitreal Dexamethasone Implant in Different Patterns of Diabetic Macular Edema
by: Claudio Furino, et al.
Published: (2020-10-01)

Risk factors for repeated dexamethasone intravitreal implant therapy for macular edema due to treatment-naïve branch retinal vein occlusion
by: Yu-Te Huang, et al.
Published: (2021-03-01)

Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema
by: Verónica Castro-Navarro, et al.
Published: (2019-01-01)

Treatment of refractory uveitic macular edema: results of a first and second implant of long-acting intravitreal dexamethasone
by: Zola M, et al.
Published: (2017-11-01)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
by: Fouda SM, et al.
Published: (2017-03-01)

Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes
by: Coelho J, et al.
Published: (2019-09-01)

Intravitreal bevacizumab (Avastin) treatment of diffuse diabetic macular edema in an Indian population
by: Kumar Atul, et al.
Published: (2007-01-01)

Cannot write session to /tmp/vufind_sessions/sess_9j88sak91hn61pbqn8rotpdffo